October 9, 2012
Dissatisfied with the Osaka District Court’s recent ruling in its patent infringement lawsuit against drug makers that market generic versions of its type 2 diabetes treatment Actos (pioglitazone), Takeda Pharmaceutical filed an appeal with the Intellectual Property High Court on...read more